Prostate Cancer Clinical Trials in Boston

Showing 101-120 of 147 trials

ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer

NCT00959959

The purpose of this study is to determine whether TOK-001 is safe and shows biological effect in the treatment of castration resistant prostate cancer (CRPC).

Prostate Cancer

LTN PHARMACEUTICALS, INC.49 participantsStarted Oct 2009

Los Angeles, California, United States • San Bernardino, California, United States • Baltimore, Maryland, United States +5 more locations

TERMINATED< 1 mile

Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

NCT01727154

The purpose of this study is to evaluate the immune response induced by sipuleucel-T (Provenge®).

Prostate Cancer

Dendreon139 participantsStarted Oct 2012

Scottsdale, Arizona, United States • Los Angeles, California, United States • Marina del Rey, California, United States +36 more locations

ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer

Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

Prostate Cancer Trials in Other Cities

Personal Web Page In Clinical Trial Participant Education

Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.

Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer

Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

Prostate Cancer Intervention Versus Observation Trial (PIVOT)

Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer

A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate Cancer

Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer

Genetic Analysis of Hereditary Prostate Cancer

A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer

Firmagon (Degarelix) Intermittent Therapy

Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer

Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer

Analyses of Human Samples Collected in Clinical Trials

Other Conditions in Boston